Oesophageal Cancer Trial, Recruiting (NCT04688801)

Oesophageal Cancer Trial, Recruiting NCT04688801 Sponsor: The Second Hospital of Shandong University Condition: Oesophageal Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04688801 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Oesophageal Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with cancer of the esophagus (food pipe) or the junction between the esophagus and stomach (certain types, known as Siewert I or II), confirmed by a tissue test.
Your heart and lung health are strong enough to safely undergo surgery.
Your cancer is able to be surgically removed, and the treatment planned is intended to manage the disease rather than cure it.

Who may not be able to join:

Your cancer is located at the lower part of the junction between the esophagus and stomach (known as Siewert III type).
Your cancer has already spread to distant parts of the body (known as M1 stage, based on the current cancer staging system).
Your heart or lung health is not strong enough to safely undergo surgery.
After surgery, a significant amount of cancer was left behind that could be seen by the surgeon (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8617660081916

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04688801

Sponsor: The Second Hospital of Shandong University

Phase: Not Applicable

Status: Recruiting

Condition: Oesophageal Cancer

Trial contact: +8617660081916

More information: https://clinicaltrials.gov/study/NCT04688801

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with cancer of the esophagus (food pipe) or the junction between the esophagus and stomach (certain types, known as Siewert I or II), confirmed by a tissue test.
Your heart and lung health are strong enough to safely undergo surgery.
Your cancer is able to be surgically removed, and the treatment planned is intended to manage the disease rather than cure it.

Who may not be able to join:

Your cancer is located at the lower part of the junction between the esophagus and stomach (known as Siewert III type).
Your cancer has already spread to distant parts of the body (known as M1 stage, based on the current cancer staging system).
Your heart or lung health is not strong enough to safely undergo surgery.
After surgery, a significant amount of cancer was left behind that could be seen by the surgeon (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The Second Hospital of Shandong University

Registry

ClinicalTrials.gov

Start date

1 July 2020

Est. completion

31 December 2023

Where this trial is recruiting

🇨🇳 China

Primary endpoints

disease free survival rate; overall survival rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov